cjc 1295 with/ipamorelin CJC-1295 and Ipamorelin Peptide Injection CJC-1295 / Ipamorelin Blend -

CJC-1295 binds the GHRH receptor (GHRH-R), a Gs-coupled GPCR on anterior pituitary somatotrophs, raising intracellular cAMP and triggering PKA-mediated GH transcription and release

Clinical Weight Loss Results In a 12-week randomized clinical trial involving 300 obese adults, subjects receiving 1 mg daily of AOD-9604 lost an average of 2.6 kg compared to 0.8 kg in the placebo group

While research in this area is ongoing, it remains to be determined whether healthy subjects may receive anabolic benefit from increased GH and IGF-1 [11]

The compounds natural mechanism and excellent safety profile supports diverse research applications and is cost effective